Angio-CT引导下经动脉化疗栓塞即刻联合射频消融治疗大肝癌
回顾性分析48例孤立性大肝癌(最大强化直径>5 cm)行Angio-CT引导下TACE即刻联合RFA,与同期48例序贯联合(TACE后2-4周行RFA)对照。即刻联合组1、3、6个月完全缓解率分别为58.3%、56.2%、47.9%,对照组为37.5%、33.3%、27.1%;1、2、3年生存率即刻联合组为95.8%、85.4%、58.3%,对照组为83.3%、68.7%、43.8%。结论认为该联合方式可行、安全,短期疗效好且长期预后改善。
要点
- 即刻联合组1、3、6个月完全缓解率分别为58.3%、56.2%、47.9%,均高于对照组。
- 即刻联合组1、2、3年生存率分别为95.8%、85.4%、58.3%,均高于对照组。
- 即刻联合技术成功率为100%,无患者出现严重并发症。
核心结论
- Angio-CT引导下TACE即刻联合RFA治疗大肝癌可行、安全,短期疗效好且长期预后改善。
研究设计与样本
- 回顾性分析,研究组48例孤立性大肝癌患者于2012年10月至2016年6月接受即刻联合治疗,对照组48例为同期接受序贯联合治疗(TACE后2-4周行RFA)的患者,随机选取。
诊断标准与关键数值
- 大肝癌定义:最大强化直径>5 cm;短期疗效采用改良实体瘤疗效评价标准评估;即刻联合技术成功率为100%;研究组1、3、6个月完全缓解率分别为58.3%、56.2%、47.9%,对照组分别为37.5%、33.3%、27.1%;研究组1、2、3年生存率分别为95.8%、85.4%、58.3%,对照组分别为83.3%、68.7%、43.8%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the method and effectiveness of Angio-CT-guided transcatheter arterial chemoembolization (TACE) immediately in combination with radiofrequency ablation (RFA) in the treatment of large hepatocellular carcinomas (HCCs; maximum enhancing diameter >5 cm).
MATERIALS AND METHODS: A retrospective analysis was conducted on 48 patients with solitary large HCCs who were admitted from October 2012 to June 2016 and treated by immediate combination therapy, and 48 patients with solitary large HCCs who were treated by a sequential combination (RFA at 2-4 weeks after TACE) therapy in the same period were randomly selected as controls. After treatment, the success rates of the immediately combined technique, the short-term outcomes of the immediately combined treatment (using the modified response evaluation criteria in solid tumor standard), and the survival rates were evaluated.
RESULTS: The success rate of the immediately combined technique was 100%. The complete remission rates 1, 3, and 6 months after treatment in the study group were 58.3%༌56.2%, and 47.9%, respectively, while the corresponding complete remission rates of control group were 37.5%, 33.3%, and 27.1%, respectively. The 1-, 2-, and 3-year survival rates of the study group were 95.8%, 85.4%, and 58.3%, respectively, while the corresponding survival rates of the control group were 83.3%, 68.7%, and 43.8%, respectively. None of the patients had any serious complications.
CONCLUSION: Angio-CT-guided TACE immediately in combination with RFA is a feasible, safe method for the treatment of large HCCs with excellent short-term outcomes and improved long-term prognoses.
引用
- Yuan H, Liu F, Li X, et al. Angio-CT-Guided Transarterial Chemoembolization Immediately in Combination with Radiofrequency Ablation for Large Hepatocellular Carcinoma. Acad Radiol. 2018. PMID: 29907399. doi:10.1016/j.acra.2018.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。